The estimated Net Worth of Alejandro D Wellisch is at least $1.15 Million dollars as of 22 November 2017. Mr. Wellisch owns over 2,153 units of Abbott Laboratories stock worth over $1,026,430 and over the last 7 years he sold ABT stock worth over $120,267. In addition, he makes $0 as Senior Vice President - Established Pharmaceuticals and Latin America at Abbott Laboratories.
Alejandro has made over 1 trades of the Abbott Laboratories stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 2,153 units of ABT stock worth $120,267 on 22 November 2017.
The largest trade he's ever made was selling 2,153 units of Abbott Laboratories stock on 22 November 2017 worth over $120,267. On average, Alejandro trades about 127 units every 0 days since 2017. As of 22 November 2017 he still owns at least 8,803 units of Abbott Laboratories stock.
You can see the complete history of Mr. Wellisch stock trades at the bottom of the page.
Alejandro Wellisch serves as Senior Vice President - Established Pharmaceuticals, Latin America of the Company. He serve as General Manager, Argentina, Bolivia, Paraguay and Uruguay, Established Pharmaceuticals.
Alejandro Wellisch is 45, he's been the Senior Vice President - Established Pharmaceuticals and Latin America of Abbott Laboratories since 2017. There are 41 older and 2 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Alejandro's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez, and Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: